These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 15691889

  • 1. Biological activity of activating thyrotrophin receptor mutants: modulation by iodide.
    Al-Khafaji F, Wiltshire M, Fuhrer D, Mazziotti G, Lewis MD, Smith PJ, Ludgate M.
    J Mol Endocrinol; 2005 Feb; 34(1):209-20. PubMed ID: 15691889
    [Abstract] [Full Text] [Related]

  • 2. Contrasting effects of activating mutations of GalphaS and the thyrotropin receptor on proliferation and differentiation of thyroid follicular cells.
    Ludgate M, Gire V, Crisp M, Ajjan R, Weetman A, Ivan M, Wynford-Thomas D.
    Oncogene; 1999 Aug 26; 18(34):4798-807. PubMed ID: 10490813
    [Abstract] [Full Text] [Related]

  • 3. Effect of iodine on early stage thyroid autonomy.
    Müller K, Krohn K, Eszlinger M, Ludgate M, Führer D.
    Genomics; 2011 Feb 26; 97(2):94-100. PubMed ID: 21035537
    [Abstract] [Full Text] [Related]

  • 4. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
    Krause K, Boisnard A, Ihling C, Ludgate M, Eszlinger M, Krohn K, Sinz A, Fuhrer D.
    Int J Biochem Cell Biol; 2012 Feb 26; 44(2):290-301. PubMed ID: 22074661
    [Abstract] [Full Text] [Related]

  • 5. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
    Porcellini A, Ruggiano G, Pannain S, Ciullo I, Amabile G, Fenzi G, Avvedimento EV.
    Oncogene; 1997 Aug 14; 15(7):781-9. PubMed ID: 9266964
    [Abstract] [Full Text] [Related]

  • 6. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.
    Fournes B, Monier R, Michiels F, Milgrom E, Misrahi M, Feunteun J.
    Oncogene; 1998 Feb 26; 16(8):985-90. PubMed ID: 9519872
    [Abstract] [Full Text] [Related]

  • 7. Functional thyrotropin receptor expression in the pituitary folliculo-stellate cell line TtT/GF.
    Brokken LJ, Bakker O, Wiersinga WM, Prummel MF.
    Exp Clin Endocrinol Diabetes; 2005 Jan 26; 113(1):13-20. PubMed ID: 15662590
    [Abstract] [Full Text] [Related]

  • 8. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.
    De Gregorio G, Coppa A, Cosentino C, Ucci S, Messina S, Nicolussi A, D'Inzeo S, Di Pardo A, Avvedimento EV, Porcellini A.
    Oncogene; 2007 Mar 29; 26(14):2039-47. PubMed ID: 17043656
    [Abstract] [Full Text] [Related]

  • 9. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
    Grasberger H, Van Sande J, Hag-Dahood Mahameed A, Tenenbaum-Rakover Y, Refetoff S.
    J Clin Endocrinol Metab; 2007 Jul 29; 92(7):2816-20. PubMed ID: 17456567
    [Abstract] [Full Text] [Related]

  • 10. Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context.
    Fuhrer D, Lewis MD, Alkhafaji F, Starkey K, Paschke R, Wynford-Thomas D, Eggo M, Ludgate M.
    Endocrinology; 2003 Sep 29; 144(9):4018-30. PubMed ID: 12933676
    [Abstract] [Full Text] [Related]

  • 11. Constitutive activation of the thyrotropin receptor by mutating CYS-636 in the sixth transmembrane segment.
    Kosugi S, Mori T.
    Biochem Biophys Res Commun; 1996 May 24; 222(3):713-7. PubMed ID: 8651910
    [Abstract] [Full Text] [Related]

  • 12. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
    Calebiro D, de Filippis T, Lucchi S, Covino C, Panigone S, Beck-Peccoz P, Dunlap D, Persani L.
    Hum Mol Genet; 2005 Oct 15; 14(20):2991-3002. PubMed ID: 16135555
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.
    Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J, Galician Group for the Study of Toxic Multinodular Goitre, Araujo Vilar D, Argueso R, Barca O, Botana M, Cabezas-Agrícola JM, Catalina P, Dominguez Gerpe L, Fernandez T, Mato A, Nuño A, Penin M, Victoria B.
    Eur J Endocrinol; 2008 Nov 15; 159(5):623-31. PubMed ID: 18694911
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.
    Sancak S, Jaeschke H, Eren F, Tarcin O, Guellueoglu B, Sen LS, Sever Z, Gozu HI, Bircan R, Akalin S, Paschke R, Eszlinger M.
    Horm Metab Res; 2011 Jul 15; 43(8):562-8. PubMed ID: 21773967
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the cyclic adenosine monophosphate pathway attenuates neuropathic pain and reduces phosphorylation of cyclic adenosine monophosphate response element-binding in the spinal cord after partial sciatic nerve ligation in rats.
    Liou JT, Liu FC, Hsin ST, Yang CY, Lui PW.
    Anesth Analg; 2007 Dec 15; 105(6):1830-7, table of contents. PubMed ID: 18042889
    [Abstract] [Full Text] [Related]

  • 16. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1.
    Fernández M, Sánchez-Franco F, Palacios N, Sánchez I, Cacicedo L.
    J Mol Endocrinol; 2005 Jun 15; 34(3):699-712. PubMed ID: 15956341
    [Abstract] [Full Text] [Related]

  • 17. The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor.
    Rossi M, Dimida A, Dell'anno MT, Trincavelli ML, Agretti P, Giorgi F, Corsini GU, Pinchera A, Vitti P, Tonacchera M, Maggio R.
    J Pharmacol Exp Ther; 2007 Jan 15; 320(1):465-74. PubMed ID: 17062616
    [Abstract] [Full Text] [Related]

  • 18. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
    Mueller S, Jaeschke H, Paschke R.
    Methods Enzymol; 2010 Jan 15; 485():421-36. PubMed ID: 21050930
    [Abstract] [Full Text] [Related]

  • 19. Thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) prevents internalization of TSH receptor.
    Picchietti S, Belardinelli M, Taddei AR, Fausto AM, Pellegrino M, Maggio R, Rossi M, Giorgi F.
    Cell Tissue Res; 2009 Apr 15; 336(1):31-40. PubMed ID: 19214582
    [Abstract] [Full Text] [Related]

  • 20. Thyrotropin receptor: a role for thyroid tumourigenesis?
    Russo D, Arturi F, Chiefari E, Filetti S.
    Forum (Genova); 1999 Apr 15; 9(2):166-75. PubMed ID: 10385711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.